Solution Structure of a Hck SH3 Domain Ligand Complex Reveals Novel Interaction Modes

Journal of Molecular Biology

Volumn 365, Issue 5, 2007, Pages 1517-1532

  Schmidt, Holger ^a,b   Hoffmann, Silke ^a,b   Tran, Tuyen ^a,b   Stoldt, Matthias ^a,b   Stangler, Thomas ^a,b   Wiesehan, Katja ^a   Willbold, Dieter ^a,b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

complex structure; human Hck; NMR; SH3 ligand interaction

Indexed keywords

HEMATOPOIETIC CELL KINASE; LIGAND; LYSINE; PROTEIN SH3; TYROSINE;

ARTICLE; COMPLEX FORMATION; LIGAND BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 33846019560     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.11.013     Document Type: Article

References (108)

1. Quintrell N., Lebo R., Varmus H., Bishop J.M., Pettenati M.J., Le Beau M., et al. Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells. Mol. Cell. Biol. 7 (1987) 2267-2275
2. Ziegler S.F., Marth J.D., Lewis D.B., and Perlmutter R.M. Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin. Mol. Cell. Biol. 7 (1987) 2276-2285
3. Fitzer-Attas C.J., Lowry M., Crowley M.T., Finn A.J., Meng F., DeFranco A.L., and Lowell C.A. Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn. J. Exp. Med. 191 (2000) 669-682
4. Durden D.L., Kim H.M., Calore B., and Liu Y. The Fc gamma RI receptor signals through the activation of hck and MAP kinase. J. Immunol. 154 (1995) 4039-4047
5. Ghazizadeh S., Bolen J.B., and Fleit H.B. Physical and functional association of Src-related protein tyrosine kinases with Fc gamma RII in monocytic THP-1 cells. J. Biol. Chem. 269 (1994) 8878-8884
6. Suen P.W., Ilic D., Caveggion E., Berton G., Damsky C.H., and Lowell C.A. Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck/Fgr deficient macrophages. J. Cell Sci. 112 (1999) 4067-4078
7. Lowell C.A., Fumagalli L., and Berton G. Deficiency of Src family kinases p59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions. J. Cell Biol. 133 (1996) 895-910
8. Bosco M.C., Curiel R.E., Zea A.H., Malabarba M.G., Ortaldo J.R., and Espinoza-Delgado I. IL-2 signaling in human monocytes involves the phosphorylation and activation of p59hck. J. Immunol. 164 (2000) 4575-4585
9. Anderson S.M., and Jorgensen B. Activation of src-related tyrosine kinases by IL-3. J. Immunol. 155 (1995) 1660-1670
10. Ernst M., Gearing D.P., and Dunn A.R. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J. 13 (1994) 1574-1584
11. Linnekin D., Howard O.M., Park L., Farrar W., Ferris D., and Longo D.L. Hck expression correlates with granulocyte-macrophage colony-stimulating factor-induced proliferation in HL-60 cells. Blood 84 (1994) 94-103
12. Carreno S., Gouze M.E., Schaak S., Emorine L.J., and Maridonneau-Parini I. Lack of palmitoylation redirects p59Hck from the plasma membrane to p61Hck-positive lysosomes. J. Biol. Chem. 275 (2000) 36223-36229
13. Scott M.P., Zappacosta F., Kim E.Y., Annan R.S., and Miller W.T. Identification of novel SH3 domain ligands for the Src family kinase Hck. Wiskott-Aldrich syndrome protein (WASP), WASP-interacting protein (WIP), and ELMO1. J. Biol. Chem. 277 (2002) 28238-28246
14. Yokoyama N., deBakker C.D., Zappacosta F., Huddleston M.J., Annan R.S., Ravichandran K.S., and Miller W.T. Identification of tyrosine residues on ELMO1 that are phosphorylated by the Src-family kinase Hck. Biochemistry 44 (2005) 8841-8849
15. Radha V., Sudhakar C., Ray P., and Swarup G. Induction of cytochrome c release and apoptosis by Hck-SH3 domain-mediated signalling requires caspase-3. Apoptosis 7 (2002) 195-207
16. Shivakrupa R., Radha V., Sudhakar C., and Swarup G. Physical and functional interaction between Hck tyrosine kinase and guanine nucleotide exchange factor C3G results in apoptosis, which is independent of C3G catalytic domain. J. Biol. Chem. 278 (2003) 52188-52194
17. Schreiner S.J., Schiavone A.P., and Smithgall T.E. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain. J. Biol. Chem. 277 (2002) 45680-45687
18. Ling S., Sheng J.Z., and Braun A.P. The calcium-dependent activity of large-conductance, calcium-activated K+ channels is enhanced by Pyk2- and Hck-induced tyrosine phosphorylation. Am. J. Physiol. Cell Physiol. 287 (2004) C698-C706
19. Mohn H., Le Cabec V., Fischer S., and Maridonneau-Parini I. The src-family protein-tyrosine kinase p59hck is located on the secretory granules in human neutrophils and translocates towards the phagosome during cell activation. Biochem. J. 309 (1995) 657-665
20. Welch H., and Maridonneau-Parini I. Hck is activated by opsonized zymosan and A23187 in distinct subcellular fractions of human granulocytes. J. Biol. Chem. 272 (1997) 102-109
21. N'Diaye E.N., Darzacq X., Astarie-Dequeker C., Daffe M., Calafat J., and Maridonneau-Parini I. Fusion of azurophil granules with phagosomes and activation of the tyrosine kinase Hck are specifically inhibited during phagocytosis of mycobacteria by human neutrophils. J. Immunol. 161 (1998) 4983-4991
22. Mocsai A., Ligeti E., Lowell C.A., and Berton G. Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck. J. Immunol. 162 (1999) 1120-1126
23. Klejman A., Schreiner S.J., Nieborowska-Skorska M., Slupianek A., Wilson M., Smithgall T.E., and Skorski T. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells. EMBO J. 21 (2002) 5766-5774
24. Lee C.H., Leung B., Lemmon M.A., Zheng J., Cowburn D., Kuriyan J., and Saksela K. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14 (1995) 5006-5015
25. Moarefi I., LaFevre Bernt M., Sicheri F., Huse M., Lee C.H., Kuriyan J., and Miller W.T. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement [see comments]. Nature 385 (1997) 650-653
26. Briggs S.D., Sharkey M., Stevenson M., and Smithgall T.E. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272 (1997) 17899-17902
27. Hassaine G., Courcoul M., Bessou G., Barthalay Y., Picard C., Olive D., et al. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein. J. Biol. Chem. 276 (2001) 16885-16893
28. Sicheri F., and Kuriyan J. Structures of Src-family tyrosine kinases. Curr. Opin. Struct. Biol. 7 (1997) 777-785
29. Horita D.A., Baldisseri D.M., Zhang W., Altieri A.S., Smithgall T.E., Gmeiner W.H., and Byrd R.A. Solution structure of the human Hck SH3 domain and identification of its ligand binding site. J. Mol. Biol. 278 (1998) 253-265
30. Arold S., O'Brien R., Franken P., Strub M.P., Hoh F., Dumas C., and Ladbury J.E. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef. Biochemistry 37 (1998) 14683-14691
31. Schindler T., Sicheri F., Pico A., Gazit A., Levitzki A., and Kuriyan J. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol. Cell 3 (1999) 639-648
32. Kaplan K.B., Bibbins K.B., Swedlow J.R., Arnaud M., Morgan D.O., and Varmus H.E. Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. EMBO J. 13 (1994) 4745-4756
33. Weng Z., Thomas S.M., Rickles R.J., Taylor J.A., Brauer A.W., Seidel-Dugan C., et al. Identification of Src, Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains. Mol. Cell. Biol. 14 (1994) 4509-4521
34. Faux M.C., and Scott J.D. More on target with protein phosphorylation: conferring specificity by location. Trends Biochem. Sci. 21 (1996) 312-315
35. Franz W.M., Berger P., and Wang J.Y. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8 (1989) 137-147
36. Jackson P., and Baltimore D. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8 (1989) 449-456
37. Superti-Furga G., Fumagalli S., Koegl M., Courtneidge S.A., and Draetta G. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 12 (1993) 2625-2634
38. Rodrigues G.A., Park M., and Schlessinger J. Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J. 16 (1997) 2634-2645
39. Xu W., Harrison S.C., and Eck M.J. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385 (1997) 595-602
40. Tran T., Hoffmann S., Wiesehan K., Jonas E., Luge C., Aladag A., and Willbold D. Insights into human Lck SH3 domain binding specificity: different binding modes of artificial and native ligands. Biochemistry 44 (2005) 15042-15052
41. Viguera A.R., Arrondo J.L., Musacchio A., Saraste M., and Serrano L. Characterization of the interaction of natural proline-rich peptides with five different SH3 domains. Biochemistry 33 (1994) 10925-10933
42. Schweimer K., Hoffmann S., Bauer F., Friedrich U., Kardinal C., Feller S.M., et al. Structural investigation of the binding of a herpesviral protein to the SH3 domain of tyrosine kinase Lck. Biochemistry 41 (2002) 5120-5130
43. Görlach M., Wittekind M., Beckman R.A., Mueller L., and Dreyfuss G. Interaction of the RNA-binding domain of the hnRNP C proteins with RNA. EMBO J. 11 (1992) 3289-3295
44. Zuiderweg E.R. Mapping protein-protein interactions in solution by NMR spectroscopy. Biochemistry 41 (2002) 1-7
45. Kohda D., Terasawa H., Ichikawa S., Ogura K., Hatanaka H., Mandiyan V., et al. Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2. Structure 2 (1994) 1029-1040
46. Engen J.R., Smithgall T.E., Gmeiner W.H., and Smith D.L. Identification and localization of slow, natural, cooperative unfolding in the hematopoietic cell kinase SH3 domain by amide hydrogen exchange and mass spectrometry. Biochemistry 36 (1997) 14384-14391
47. Palencia A., Cobos E.S., Mateo P.L., Martinez J.C., and Luque I. Thermodynamic dissection of the binding energetics of proline-rich peptides to the Abl-SH3 domain: implications for rational ligand design. J. Mol. Biol. 336 (2004) 527-537
48. Feng S., Chen J.K., Yu H., Simon J.A., and Schreiber S.L. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266 (1994) 1241-1247
49. Yu H., Chen J.K., Feng S., Dalgarno D.C., Brauer A.W., and Schreiber S.L. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76 (1994) 933-945
50. Renzoni D.A., Pugh D.J., Siligardi G., Das P., Morton C.J., Rossi C., et al. Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of PI3-kinase. Biochemistry 35 (1996) 15646-15653
51. Pisabarro M.T., Serrano L., and Wilmanns M. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions. J. Mol. Biol. 281 (1998) 513-521
52. Ghose R., Shekhtman A., Goger M.J., Ji H., and Cowburn D. A novel, specific interaction involving the Csk SH3 domain and its natural ligand. Nature Struct. Biol. 8 (2001) 998-1004
53. Bauer F., Schweimer K., Meiselbach H., Hoffmann S., Rosch P., and Sticht H. Structural characterization of Lyn-SH3 domain in complex with a herpesviral protein reveals an extended recognition motif that enhances binding affinity. Protein Sci. 14 (2005) 2487-2498
54. Lim W.A., and Richards F.M. Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition. Nature Struct. Biol. 1 (1994) 221-225
55. Cowan P.M., McGavin S., and North A.C. The polypeptide chain configuration of collagen. Nature 176 (1955) 1062-1064
56. Williams J.C., Wierenga R.K., and Saraste M. Insights into Src kinase functions: structural comparisons. Trends Biochem. Sci. 23 (1998) 179-184
57. Pellecchia M., Iwai H., Szyperski T., and Wuthrich K. The 2D NMR experiments H(C)CO2 and HCCO2 for assignment and pH titration of carboxylate groups in uniformly 15N/13C-labeled proteins. J. Magn. Reson. 124 (1997) 274-278
58. Fernandez-Ballester G., Blanes-Mira C., and Serrano L. The tryptophan switch: changing ligand-binding specificity from type I to type II in SH3 domains. J. Mol. Biol. 335 (2004) 619-629
59. Musacchio A., Saraste M., and Wilmanns M. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nature Struct. Biol. 1 (1994) 546-551
60. Alexandropoulos K., Cheng G., and Baltimore D. Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc. Natl Acad. Sci. USA 92 (1995) 3110-3114
61. Landgraf C., Panni S., Montecchi-Palazzi L., Castagnoli L., Schneider-Mergener J., Volkmer-Engert R., and Cesareni G. Protein interaction networks by proteome peptide scanning. PLoS Biol. 2 (2004) E14
62. Cheng G., Ye Z.S., and Baltimore D. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc. Natl Acad. Sci. USA 91 (1994) 8152-8155
63. Feng S., Kasahara C., Rickles R.J., and Schreiber S.L. Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc. Natl Acad. Sci. USA 92 (1995) 12408-12415
64. Sparks A.B., Rider J.E., Hoffman N.G., Fowlkes D.M., Quillam L.A., and Kay B.K. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2. Proc. Natl Acad. Sci. USA 93 (1996) 1540-1544
65. Mongiovi A.M., Romano P.R., Panni S., Mendoza M., Wong W.T., Musacchio A., et al. A novel peptide-SH3 interaction. EMBO J. 18 (1999) 5300-5309
66. Lewitzky M., Kardinal C., Gehring N.H., Schmidt E.K., Konkol B., Eulitz M., et al. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif. Oncogene 20 (2001) 1052-1062
67. Espanel X., and Sudol M. Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J. Biol. Chem. 276 (2001) 14514-14523
68. Fazi B., Cope M.J., Douangamath A., Ferracuti S., Schirwitz K., Zucconi A., et al. Unusual binding properties of the SH3 domain of the yeast actin-binding protein Abp1: structural and functional analysis. J. Biol. Chem. 277 (2002) 5290-5298
69. Kang H., Freund C., Duke-Cohan J.S., Musacchio A., Wagner G., and Rudd C.E. SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55. EMBO J. 19 (2000) 2889-2899
70. Kowanetz K., Szymkiewicz I., Haglund K., Kowanetz M., Husnjak K., Taylor J.D., et al. Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors. J. Biol. Chem. 278 (2003) 39735-39746
71. Brannetti B., Via A., Cestra G., Cesareni G., and Citterich M.H. SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family. J. Mol. Biol. 298 (2000) 313-328
72. Brannetti B., and Helmer-Citterich M. iSPOT: a web tool to infer the interaction specificity of families of protein modules. Nucl. Acids Res. 31 (2003) 3709-3711
73. Brannetti B., Zanzoni A., Montecchi-Palazzi L., Cesareni G., and Helmer-Citterich M. iSPOT: a web tool for the analysis and recognition of protein domain specificity. Comp. Funct. Genomics 2 (2001) 314-318
74. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., and Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl. Acids Res. 25 (1997) 3389-3402
75. Harada T., Nishie A., Torigoe K., Ikezaki K., Shono T., Maehara Y., et al. The specific expression of three novel splice variant forms of human metalloprotease-like disintegrin-like cysteine-rich protein 2 gene in Brain tissues and gliomas. Jpn. J. Cancer Res. 91 (2000) 1001-1006
76. Sagane K., Ohya Y., Hasegawa Y., and Tanaka I. Metalloproteinase-like, disintegrin-like, cysteine-rich proteins MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brain. Biochem. J. 334 (1998) 93-98
77. Zhu P., Sun Y., Xu R., Sang Y., Zhao J., Liu G., et al. The interaction between ADAM 22 and 14-3-3zeta: regulation of cell adhesion and spreading. Biochem. Biophys. Res. Commun. 301 (2003) 991-999
78. Zhu P., Sang Y., Xu H., Zhao J., Xu R., Sun Y., et al. ADAM22 plays an important role in cell adhesion and spreading with the assistance of 14-3-3. Biochem. Biophys. Res. Commun. 331 (2005) 938-946
79. Poghosyan Z., Robbins S.M., Houslay M.D., Webster A., Murphy G., and Edwards D.R. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases. J. Biol. Chem. 277 (2002) 4999-5007
80. D'Abaco G.M., Ng K., Paradiso L., Godde N.J., Kaye A., and Novak U. ADAM22, expressed in normal brain but not in high-grade gliomas, inhibits cellular proliferation via the disintegrin domain. Neurosurgery 58 (2006) 179-186
81. Lowell C.A., and Berton G. Integrin signal transduction in myeloid leukocytes. J. Leukoc. Biol. 65 (1999) 313-320
82. Tang R.H., Law S.K., and Tan S.M. Selective recruitment of src family kinase Hck by leukocyte integrin alphaMbeta2 but not alphaLbeta2 or alphaXbeta2. FEBS Letters 580 (2006) 4435-4442
83. Arias-Salgado E.G., Lizano S., Sarkar S., Brugge J.S., Ginsberg M.H., and Shattil S.J. Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc. Natl Acad. Sci. USA 100 (2003) 13298-13302
84. Stettner M.R., Wang W., Nabors L.B., Bharara S., Flynn D.C., Grammer J.R., et al. Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells. Cancer Res. 65 (2005) 5535-5543
85. Lowell C.A. Src-family kinases: rheostats of immune cell signaling. Mol. Immunol. 41 (2004) 631-643
86. Björklund M., Aitio O., Stefanidakis M., Suojanen J., Salo T., Sorsa T., and Koivunen E. Stabilization of the activated aMb2 integrin by a small molecule inhibits leukocyte migration and recruitment. Biochemistry 45 (2006) 2862-2871
87. Li H., and Lawrence D.S. Acquisition of Fyn-selective SH3 domain ligands via a combinatorial library strategy. Chem. Biol. 12 (2005) 905-912
88. Maniatis T., Fritsch E.F., and Sambrook J. Molecular Cloning, A Laboratory Manual (1982), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
89. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
90. Keller R. The Computer Aided Resonance Assignment Tutorial (2004), CANTINA, Goldau, Switzerland
91. Bodenhausen G., and Ruben D.J. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy. Chem. Phys. Letters 69 (1980) 185
92. Grzesiek S., and Bax A. Amino acid type determination in the sequential assignment procedure of uniformly 13C/15N-enriched proteins. J. Biomol. NMR 3 (1993) 185-204
93. Wittekind M., and Mueller L. HNCACB, a high-sensitivity 3D NMR experiment to correlate amide-proton and nitrogen resonances with the a- and β-carbon resonances in proteins. J. Magn. Reson. 101B (1993) 201-205
94. Kay L.E., Keifer P., and Saarinen T. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 114 (1992) 10663-10665
95. Ikura M., Kay L.E., and Bax A. A novel approach for sequential assignment of 1H, 13C, and 15N spectra of proteins: heteronuclear triple-resonance three-dimensional NMR spectroscopy. Application to calmodulin. Biochemistry 29 (1990) 4659-4667
96. 15N-enriched proteins. J. Am. Chem. Soc. 115 (1993) 7772-7777
97. 13C magnetization. J. Magn. Reson. 101B (1993) 114-119
98. Bax A., Clore M., Driscoll P.C., Gronenborn A.M., Ikura M., and Kay L.E. Practical aspects of proton-carbon-carbon-proton three-dimensional correlation spectroscopy of 13C-labeled proteins. J. Magn. Reson. 87 (1990) 620-627
99. 13C-labeled proteins via scalar couplings. J. Am. Chem. Soc. 115 (1993) 11054-11055
100. Ikura M., and Bax A. Isotope-filtered 2D NMR of a protein-peptide complex: study of a skeletal muscle myosin light chain kinase fragment bound to calmodulin. J. Am. Chem. Soc. 114 (1992) 2433-2440
101. Zuiderweg E.R., and Fesik S.W. Heteronuclear three-dimensional NMR spectroscopy of the inflammatory protein C5a. Biochemistry 28 (1989) 2387-2391
102. 15N spectroscopy. J. Magn. Reson. 87 (1990) 488-501
103. Zwahlen C., Legault P., Vincent S.J.F., Greenblatt J., Konrat R., and Kay L.E. Methods for measurement of intermolecular NOEs by multinuclear NMR spectroscopy: application to a bacteriophage λ N-peptide/boxB RNA complex. J. Am. Chem. Soc. 119 (1997) 6711-6721
104. Herrmann T., Guntert P., and Wuthrich K. Protein NMR structure determination with automated NOE-identification in the NOESY spectra using the new software ATNOS. J. Biomol. NMR 24 (2002) 171-189
105. Herrmann T., Guntert P., and Wuthrich K. Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J. Mol. Biol. 319 (2002) 209-227
106. Guntert P., Mumenthaler C., and Wuthrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 273 (1997) 283-298
107. Laskowski R.A., Rullmann J.A.C., MacArthur M.W., Kaptein R., and Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8 (1996) 477-486
108. Koradi, R., Billeter, M., Wuthrich, K. (1996). MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics, 14, 51-5, 29-32.